Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
50 - To restrict access to patient web site we usually use the DIN as an accepted method of verifying that the visitor is indeed a patient before granting access. But we are currently working on a web site for a drug where the patients never receive the product packaging. Some of them might be able to find the DIN on their drug store receipt but some receipts don't have that information. Are there other accepted methods of restricting access to a patient web site in case the DIN is not available?
-
Yes there are other methods of restricting web access to specific patients. Alternatively to a DIN password, healthcare professionals (doctors or pharmacists) could provide the individual patient sign-up information to mail in or go to a web-site url to register for access and obtain a password. The onus is on the sponsor to gate access to the product information to ensure that only patients taking the product have access to the site.
-
@Jennifer-Carroll Would you agree that this unique URL provided by the physician to the patient should not contain any keywords that could allow patients to find the website while doing a search for the disease state or the product in question?
